eFFECTOR Therapeutics (EFTR)
NASDAQ:EFTR

eFFECTOR Therapeutics (EFTR) Stock Price & Analysis

78 Followers

EFTR Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.36 - $5.97
Previous Close$0.51
Volume210.60K
Average Volume (3M)299.51K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)3.6
Beta-0.09
Next EarningsMar 15, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
EPS (TTM)0.14
Shares Outstanding41,893,140
R-Squared0.00220
Standard Deviation0.21
10 Day Avg. Volume660,896
30 Day Avg. Volume299,514
Price to Book (P/B)1.64
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-1.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside750.85% Upside
Rating ConsensusStrong Buy
Alpha-0.12
Number of Analyst Covering4


Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

EFTR FAQ

What was eFFECTOR Therapeutics’s price range in the past 12 months?
eFFECTOR Therapeutics lowest stock price was $0.36 and its highest was $5.97 in the past 12 months.
    What is eFFECTOR Therapeutics’s market cap?
    Currently, no data Available
    When is eFFECTOR Therapeutics’s upcoming earnings report date?
    eFFECTOR Therapeutics’s upcoming earnings report date is Mar 15, 2023 which is in 45 days.
      How were eFFECTOR Therapeutics’s earnings last quarter?
      eFFECTOR Therapeutics released its earnings results on Nov 07, 2022. The company reported -$0.23 earnings per share for the quarter, missing the consensus estimate of -$0.214 by -$0.016.
        Is eFFECTOR Therapeutics overvalued?
        According to Wall Street analysts eFFECTOR Therapeutics’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does eFFECTOR Therapeutics pay dividends?
          eFFECTOR Therapeutics does not currently pay dividends.
          What is eFFECTOR Therapeutics’s EPS estimate?
          eFFECTOR Therapeutics’s EPS estimate is -$0.24.
            How many shares outstanding does eFFECTOR Therapeutics have?
            eFFECTOR Therapeutics has 41,348,310 shares outstanding.
              What happened to eFFECTOR Therapeutics’s price movement after its last earnings report?
              eFFECTOR Therapeutics reported an EPS of -$0.23 in its last earnings report, missing expectations of -$0.214. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of eFFECTOR Therapeutics?
                Among the largest hedge funds holding eFFECTOR Therapeutics’s share is Blackstone Inc.. It holds eFFECTOR Therapeutics’s shares valued at 749K.

                  ---

                  eFFECTOR Therapeutics Stock Smart Score

                  N/A
                  Not Ranked
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10

                  Technicals

                  SMA
                  Negative
                  20 days / 200 days
                  Momentum
                  -90.67%
                  12-Months-Change

                  Fundamentals

                  Return on Equity
                  290.11%
                  Trailing 12-Months
                  Asset Growth
                  -38.85%
                  Trailing 12-Months
                  This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
                  Learn more about TipRanks Smart Score

                  Company Description

                  eFFECTOR Therapeutics

                  Locust Walk Acquisition Corp is a blank check company.

                  ---

                  Forecast EPS vs Actual EPS


                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Minerva Neurosciences
                  Blue Water Vaccines, Inc.
                  Aridis Pharmaceuticals
                  Metacrine
                  Catalyst Biosciences

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis